A re-evaluation of random-effects meta-analysis.

PubWeight™: 5.81‹?› | Rank: Top 1%

🔗 View Article (PMID 19381330)

Published in J R Stat Soc Ser A Stat Soc on January 01, 2009

Authors

Julian P T Higgins1, Simon G Thompson, David J Spiegelhalter

Author Affiliations

1: Medical Research Council Biostatistics Unit Cambridge, UK.

Articles citing this

(truncated to the top 100)

Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78

Multivariate meta-analysis: potential and promise. Stat Med (2011) 5.26

Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia (2012) 4.82

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet (2014) 4.11

Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol (2010) 3.97

Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis. BMJ (2010) 3.32

Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS (2012) 3.05

Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol (2012) 2.58

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods (2012) 2.57

Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med (2012) 2.52

Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43

Sequential methods for random-effects meta-analysis. Stat Med (2010) 2.33

Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ (2013) 2.28

The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS (2013) 2.17

Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97

Replication in genome-wide association studies. Stat Sci (2009) 1.89

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ (2013) 1.74

Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS One (2012) 1.70

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ (2013) 1.70

Multivariate meta-analysis for non-linear and other multi-parameter associations. Stat Med (2012) 1.68

Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev (2011) 1.67

Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries. PLoS One (2014) 1.65

Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in overweight and obese people. Cochrane Database Syst Rev (2010) 1.61

Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One (2012) 1.50

Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environ Health Perspect (2013) 1.49

Treatment effects of fixed functional appliances in patients with Class II malocclusion: a systematic review and meta-analysis. Eur J Orthod (2015) 1.34

Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One (2013) 1.34

A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev (2013) 1.28

Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord (2012) 1.26

Evaluating the quality of evidence from a network meta-analysis. PLoS One (2014) 1.26

Screening for postnatal depression in primary care: cost effectiveness analysis. BMJ (2009) 1.25

Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making (2013) 1.25

Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations. PLoS One (2011) 1.24

A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21

The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med Res Methodol (2015) 1.19

On genome-wide association studies and their meta-analyses: lessons learned from osteoporosis studies. J Clin Endocrinol Metab (2013) 1.18

Systematic review of methods for individual patient data meta- analysis with binary outcomes. BMC Med Res Methodol (2014) 1.17

Selenium for preventing cancer. Cochrane Database Syst Rev (2014) 1.17

Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making (2013) 1.16

Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol (2012) 1.15

Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. Am J Hum Genet (2009) 1.14

Bayesian methods for the design and interpretation of clinical trials in very rare diseases. Stat Med (2014) 1.14

Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol (2014) 1.11

A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev (2010) 1.10

Combining multiple imputation and meta-analysis with individual participant data. Stat Med (2013) 1.07

The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg (2015) 1.06

A random effects variance shift model for detecting and accommodating outliers in meta-analysis. BMC Med Res Methodol (2011) 1.06

Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care (2010) 1.05

Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clin Nutr (2011) 1.04

Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev (2010) 1.04

Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev (2010) 1.03

Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. PLoS One (2014) 1.03

Effects of exercise in the treatment of overweight and obese children and adolescents: a systematic review of meta-analyses. J Obes (2013) 1.02

Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol Biomarkers Prev (2013) 1.01

Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol (2014) 1.00

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int (2014) 1.00

Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98

Meta-analysis of safety for low event-rate binomial trials. Res Synth Methods (2012) 0.97

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet (2016) 0.93

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med (2015) 0.93

Re-Infection Outcomes Following One- And Two-Stage Surgical Revision of Infected Knee Prosthesis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.93

The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review. AIDS (2014) 0.93

Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open (2016) 0.92

Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. Arthritis Res Ther (2015) 0.92

Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. Am J Epidemiol (2013) 0.92

Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis. PLoS One (2016) 0.91

Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am Heart J (2010) 0.90

Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev (2010) 0.89

Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model. J Clin Epidemiol (2015) 0.89

Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials. Int J Endocrinol (2013) 0.88

Fully Bayesian hierarchical modelling in two stages, with application to meta-analysis. J R Stat Soc Ser C Appl Stat (2013) 0.87

Meta-analyses: with confidence or prediction intervals? Eur J Epidemiol (2012) 0.86

Effect of fruit juice on glucose control and insulin sensitivity in adults: a meta-analysis of 12 randomized controlled trials. PLoS One (2014) 0.86

Summarising and validating test accuracy results across multiple studies for use in clinical practice. Stat Med (2015) 0.85

Efficacy of Pregabalin in Acute Postoperative Pain Under Different Surgical Categories: A Meta-Analysis. Medicine (Baltimore) (2015) 0.85

Natural vitamin C intake and the risk of head and neck cancer: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2015) 0.85

Paradoxical ventilator associated pneumonia incidences among selective digestive decontamination studies versus other studies of mechanically ventilated patients: benchmarking the evidence base. Crit Care (2011) 0.85

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis. BMC Med (2012) 0.85

Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. ILAR J (2014) 0.85

Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium. Eur J Epidemiol (2013) 0.84

Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med (2015) 0.84

Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis. Asian J Androl (2016) 0.83

Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2014) 0.83

Assessing discriminative ability of risk models in clustered data. BMC Med Res Methodol (2014) 0.83

A note on the graphical presentation of prediction intervals in random-effects meta-analyses. Syst Rev (2012) 0.83

Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials. BMC Infect Dis (2015) 0.83

Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res (2016) 0.82

Effects of exercise on BMI z-score in overweight and obese children and adolescents: a systematic review with meta-analysis. BMC Pediatr (2014) 0.82

Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis. Asian J Androl (2016) 0.82

Effects of exercise on depressive symptoms in adults with arthritis and other rheumatic disease: a systematic review of meta-analyses. BMC Musculoskelet Disord (2014) 0.82

Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One (2012) 0.82

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis. Int J Rheumatol (2014) 0.81

A Systematic Review and Meta-Analysis of Medical Students' Perspectives on the Engagement in Research. Medicine (Baltimore) (2015) 0.81

Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group. Syst Rev (2013) 0.81

Meditative Movement Therapies and Health-Related Quality-of-Life in Adults: A Systematic Review of Meta-Analyses. PLoS One (2015) 0.81

Effects of zinc supplementation on the incidence of mortality in preschool children: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.81

Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis. J Gen Intern Med (2016) 0.81

Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Syst Rev (2014) 0.81

Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open (2015) 0.80

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ (1998) 22.62

Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65

How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy (2002) 8.49

Detecting and describing heterogeneity in meta-analysis. Stat Med (1998) 8.44

Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials (2006) 6.11

Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med (1999) 5.78

Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86

A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med (1991) 4.85

A random-effects regression model for meta-analysis. Stat Med (1995) 4.83

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56

Borrowing strength from external trials in a meta-analysis. Stat Med (1996) 4.23

The interpretation of random-effects meta-analysis in decision models. Med Decis Making (2005) 3.98

On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics (2001) 3.83

Testing for qualitative interactions between treatment effects and patient subsets. Biometrics (1985) 3.71

Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med (1995) 3.71

Why sources of heterogeneity in meta-analysis should be investigated. BMJ (1994) 3.68

Why do we need systematic overviews of randomized trials? Stat Med (1987) 3.33

Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol (1995) 3.10

How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95

Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86

Meta-analysis: statistical alchemy for the 21st century. J Clin Epidemiol (1995) 2.83

Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74

A likelihood approach to meta-analysis with random effects. Stat Med (1996) 2.54

A systematic review and meta-analysis of set-shifting ability in eating disorders. Psychol Med (2007) 2.46

Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med (1997) 2.08

Confidence intervals for the amount of heterogeneity in meta-analysis. Stat Med (2007) 2.05

Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90

A bivariate approach to meta-analysis. Stat Med (1993) 1.90

Valid inference in random effects meta-analysis. Biometrics (1999) 1.89

Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med (2003) 1.84

A general maximum likelihood analysis of variance components in generalized linear models. Biometrics (1999) 1.70

Flexible parametric models for random-effects distributions. Stat Med (2008) 1.61

A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med (2001) 1.33

Using empirical Bayes methods in biopharmaceutical research. Stat Med (1991) 1.33

Investigating causes of heterogeneity in systematic reviews. Stat Med (2002) 1.32

Assessing the amount of heterogeneity in random-effects meta-analysis. Biom J (2006) 1.32

Hierarchical models for multicentre binary response studies. Stat Med (1990) 1.31

On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med (2001) 1.27

Maximum likelihood analysis for heteroscedastic one-way random effects ANOVA in interlaboratory studies. Biometrics (1999) 1.27

Inter-study differences: how should they influence the interpretation and analysis of results? Stat Med (1987) 1.24

A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease. Stat Med (2003) 1.15

Exploratory or analytic meta-analysis: should we distinguish between them? J Clin Epidemiol (1995) 1.07

Meta-analysis by random effect modelling in generalized linear models. Stat Med (1999) 1.02

A comparison of the power of two tests for qualitative interactions. Stat Med (1993) 1.01

Test for qualitative interaction of clinical significance. Stat Med (1997) 0.93

Approximate Bayesian inference for random effects meta-analysis. Stat Med (1998) 0.87

Meta-analysis: a unifying meta-likelihood approach framing unobserved heterogeneity, study covariates, publication bias, and study quality. Methods Inf Med (2005) 0.85

Accumulating evidence from independent studies: what we can win and what we can lose. Stat Med (1987) 0.84

Articles by these authors

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83

Controlling the risk of spurious findings from meta-regression. Stat Med (2004) 6.80

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials (2004) 5.26

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet (2012) 4.16

Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65

A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med (2007) 3.27

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19

Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation (2004) 3.07

Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med (2010) 3.07

Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ (2014) 2.98

Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74

Adjusting for partially missing baseline measurements in randomized trials. Stat Med (2005) 2.70

Methodological challenges in online trials. J Med Internet Res (2009) 2.64

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol (2012) 2.58

Poorer self assessed health in a prospective study of men with screen detected abdominal aortic aneurysm: a predictor or a consequence of screening outcome? J Epidemiol Community Health (2004) 2.42

Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol (2013) 2.34

Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27

Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol (2006) 2.22

Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control (2006) 2.17

Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 2.14

Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol (2013) 2.06

Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05

A note on the power prior. Stat Med (2009) 1.93

Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92

Clustering by health professional in individually randomised trials. BMJ (2005) 1.85

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Clin Trials (2004) 1.85

Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol (2002) 1.82

Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol (2011) 1.75

Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ (2012) 1.70

Impact and costs of incentives to reduce attrition in online trials: two randomized controlled trials. J Med Internet Res (2011) 1.66

A collaboratively-derived science-policy research agenda. PLoS One (2012) 1.63

Flexible parametric models for random-effects distributions. Stat Med (2008) 1.61

On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption. PLoS One (2011) 1.61

Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology (2014) 1.58

The DYD-RCT protocol: an on-line randomised controlled trial of an interactive computer-based intervention compared with a standard information website to reduce alcohol consumption among hazardous drinkers. BMC Public Health (2007) 1.56

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Clin Trials (2004) 1.53

Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol (2015) 1.51

The use of random effects models to allow for clustering in individually randomized trials. Clin Trials (2005) 1.50

Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med (2011) 1.44

Summarizing historical information on controls in clinical trials. Clin Trials (2010) 1.38

Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes. Stat Med (2012) 1.27

Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ (2005) 1.25

Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture. Biom J (2011) 1.19

Uncertainty and validation of health economic decision models. Health Econ (2010) 1.17

Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial. Stat Med (2011) 1.16

Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data. Stat Med (2013) 1.16

Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies. PLoS One (2011) 1.11

Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Making (2011) 1.10

A framework for addressing structural uncertainty in decision models. Med Decis Making (2011) 1.09

A framework for quantifying net benefits of alternative prognostic models. Stat Med (2011) 1.08

Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg (2010) 1.07

Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Stat Med (2004) 1.04

The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials (2014) 1.04

Use of the false discovery rate when comparing multiple health care providers. J Clin Epidemiol (2007) 1.04

Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome? Stat Methods Med Res (2007) 1.03

Optimal multistage designs for randomised clinical trials with continuous outcomes. Stat Med (2011) 1.03

Accounting for uncertainty in health economic decision models by using model averaging. J R Stat Soc Ser A Stat Soc (2009) 1.02

The rupture rate of large abdominal aortic aneurysms: is this modified by anatomical suitability for endovascular repair? Ann Surg (2008) 1.02

Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01

Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials. Clin Trials (2005) 1.01

Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA (2013) 1.01

Impact of length or relevance of questionnaires on attrition in online trials: randomized controlled trial. J Med Internet Res (2011) 1.01

Understanding uncertainty. Ann Fam Med (2008) 1.00

Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98

Choice of test for comparing two groups, with particular application to skewed outcomes. Stat Med (2003) 0.98

Modelling multiple sources of dissemination bias in meta-analysis. Stat Med (2010) 0.97

Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol (2013) 0.95

Derivation and assessment of risk prediction models using case-cohort data. BMC Med Res Methodol (2013) 0.95

Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ (2005) 0.95

Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease. Int J Epidemiol (2013) 0.94

Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials. Health Econ (2012) 0.94

Missing data methods in Mendelian randomization studies with multiple instruments. Am J Epidemiol (2011) 0.93

Survival models in health economic evaluations: balancing fit and parsimony to improve prediction. Int J Biostat (2010) 0.93

Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93

Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis. Pharm Stat (2012) 0.91

Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studies. BMC Public Health (2011) 0.91

A modelling strategy for the analysis of clinical trials with partly missing longitudinal data. Int J Methods Psychiatr Res (2003) 0.90

Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am Heart J (2010) 0.90

Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology (2017) 0.88

Renal function and abdominal aortic aneurysm (AAA): the impact of different management strategies on long-term renal function in the UK EndoVascular Aneurysm Repair (EVAR) Trials. Ann Surg (2010) 0.88

Flexible design and efficient implementation of adaptive dose-finding studies. J Biopharm Stat (2007) 0.87

The importance of varying the event generation process in simulation studies of statistical methods for recurrent events. Stat Med (2006) 0.87

Accounting for regression-to-the-mean in tests for recent changes in institutional performance: analysis and power. Stat Med (2009) 0.86

Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials. Stat Med (2006) 0.86

Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials. Med Decis Making (2009) 0.85

Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat (2010) 0.84